Bioaffinity Technologies, INC. (BIAF) — SEC Filings
Latest SEC filings for Bioaffinity Technologies, INC.. Recent 8-K filing on Mar 26, 2026. AI-decoded analysis of earnings, risk factors, and insider trades
View Bioaffinity Technologies, INC. on SEC EDGAR
Overview
Bioaffinity Technologies, INC. (BIAF) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Mar 26, 2026: bioAffinity Technologies, Inc. filed an 8-K on March 26, 2026, under Item 7.01, Regulation FD Disclosure, indicating they are publicly disclosing information that was not previously made public. This filing includes an exhibit, EX-99.1, which often contains a press release or investor presentation.
Sentiment Summary
Across 1 filings, the sentiment breakdown is: 1 neutral. The dominant filing sentiment for Bioaffinity Technologies, INC. is neutral.
Filing Type Overview
Bioaffinity Technologies, INC. (BIAF) has filed 1 8-K with the SEC between Mar 2026.
Recent Filings (1)
-
bioAffinity Tech Files 8-K: Regulation FD Disclosure on March 26, 2026
— 8-K · Mar 26, 2026
bioAffinity Technologies, Inc. filed an 8-K on March 26, 2026, under Item 7.01, Regulation FD Disclosure, indicating they are publicly disclosing information th
Top Tags
regulation-fd (1) · disclosure (1) · corporate-action (1)
Frequently Asked Questions
What are the latest SEC filings for Bioaffinity Technologies, INC. (BIAF)?
Bioaffinity Technologies, INC. has 1 recent SEC filings from Mar 2026, including 1 8-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of BIAF filings?
Across 1 filings, the sentiment breakdown is: 1 neutral. The dominant sentiment is neutral.
Where can I find Bioaffinity Technologies, INC. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Bioaffinity Technologies, INC. (BIAF) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Bioaffinity Technologies, INC.?
Financial highlights for Bioaffinity Technologies, INC. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for BIAF?
Investment thesis data for BIAF will be available once enriched filings are processed.
Who are the key executives at Bioaffinity Technologies, INC.?
Executive information for Bioaffinity Technologies, INC. is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Bioaffinity Technologies, INC. stock?
Risk factor analysis for Bioaffinity Technologies, INC. is available when filings are enriched with AI risk assessment.
What are recent predictions and forward guidance from Bioaffinity Technologies, INC.?
Forward guidance and predictions for Bioaffinity Technologies, INC. are extracted from SEC filings as they are enriched.